Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets.
about
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics TestingComparison of insertion/deletion calling algorithms on human next-generation sequencing data.Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management.EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53First case of B ALL with KMT2A-MAML2 rearrangement: a case reportDetection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNADNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous LeukemiaWhole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.ScanIndel: a hybrid framework for indel detection via gapped alignment, split reads and de novo assemblyDesign and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene TestingA novel approach for next-generation sequencing of circulating tumor cellsNext Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid TumorsStatistical method to compare massive parallel sequencing pipelines.Multiple Gastrointestinal Polyps in Patients Treated with BRAF Inhibitors.Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.Enabling the democratization of the genomics revolution with a fully integrated web-based bioinformatics platform.Reference standards for next-generation sequencing.The State of the Art in Colorectal Cancer Molecular Biomarker Testing.Genomic Selection in the Era of Next Generation Sequencing for Complex Traits in Plant BreedingClinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution.Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.Whole-Genome Sequencing of a Family with Hereditary Pulmonary Alveolar Proteinosis Identifies a Rare Structural Variant Involving CSF2RA/CRLF2/IL3RA Gene Disruption.Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.ROS1 Rearrangement in a Case of Classic Biphasic Pulmonary Blastoma.Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma.In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The φ-Index.Co-sequencing and novel delayed anti-correlation identify function for pancreatic enriched microRNA biomarkers in a rat model of acute pancreatic injury.Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.
P2860
Q28079766-275FA269-6AEF-4D34-A483-359E05C4705BQ30872524-00F9DECE-B5D0-4C98-9B3F-6335690A2735Q31160887-2AB41751-750C-4237-B531-D7575904EB4EQ33594139-BB0C92F6-0135-458D-B955-617CA3A5529BQ33721982-93D2ABC8-7B36-488C-BF2A-4D67D87AF528Q33737740-ADD8E420-8767-4E46-AA0C-1A26AD15E4E5Q34667618-FC32452F-131D-4734-B927-74C6E1B089E6Q34998940-3153D4AA-29AF-4E6B-B953-CB30F29DFC1DQ35862760-51C340D5-3D05-4E9B-924F-4DD5E71A8E26Q35924308-E364ABBF-78AE-4C77-9320-A42E5C017515Q35979104-6BC17DB3-240F-433A-B580-BA5DD2E06B3DQ36088952-7EAC960A-A31B-4D19-928F-B6B656792BECQ36147793-66AA4B16-4F99-442B-A931-88E8D02DA5DAQ36294391-F4BF9ED1-205B-482F-8F75-238F52845AC7Q36342842-683E4EDC-66AB-40B6-A4B1-C502BD251F6CQ37517553-6EF045C9-887F-44C3-8639-66247797744AQ37577371-77947721-EAA7-4157-A4C2-8F26DD2D2A49Q38669617-9C7CA727-7305-4C1E-AE7C-3830C473F577Q38724312-F7068E40-DF5D-481B-8104-23DC44C0F724Q38771067-E5DA0197-7D76-4441-9C0A-2515DDCAEE57Q39754979-1749F23E-497F-4DA9-99C0-DAA24E5B5A17Q40091164-11B612FA-96FC-4C42-83AD-B32EFF76DE7BQ40203060-7A657261-CB74-4599-AE14-33AF5137B8C0Q40319198-E422FF4A-BED5-407D-8119-9F7C6742B22FQ42705413-F2EE227C-2794-4A8A-9BD6-83ACCD19FE0FQ47689771-C482070F-7AD4-4750-BD1E-E52629219024Q48319478-257F0ECC-3451-4BFD-A17C-B8F5F049AF72Q49097031-1F71AB31-46BE-4F06-855C-697C9E9FCEF6Q50099671-75A9087E-774A-4FD5-A943-F697803AFF41Q51732438-062635E4-5162-4B93-AEC9-AC3DBEFC667FQ52097937-A95847D2-2814-4F5A-8504-22161B4F4C46Q52560717-A8BEE8E2-9889-408C-A663-644D62B00183Q52758680-33BFC882-EC5A-4714-B627-E14A51A594ABQ53808986-30B2438E-56DF-4683-9B0C-4AFABD6AA4B8
P2860
Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Understanding the limitations ...... on using artificial data sets.
@ast
Understanding the limitations ...... on using artificial data sets.
@en
type
label
Understanding the limitations ...... on using artificial data sets.
@ast
Understanding the limitations ...... on using artificial data sets.
@en
prefLabel
Understanding the limitations ...... on using artificial data sets.
@ast
Understanding the limitations ...... on using artificial data sets.
@en
P2093
P1433
P1476
Understanding the limitations ...... on using artificial data sets.
@en
P2093
Jennifer J D Morrissette
Robert Daber
Shrey Sukhadia
P304
P356
10.1016/J.CANCERGEN.2013.11.005
P577
2013-11-28T00:00:00Z